EP2654789

INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Application Number
EP11801741A
Filing Date
Dec 21, 2011
Status
Revoked
Sep 6, 2024
Grant Date
May 30, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2654789B1 was granted on May 30, 2018 by Inserm - Institut National De La Santé Et De La Recherche Médicale The patent is currently Revoked.

The table below shows 4 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANT LLPFeb 28, 2019ADMISSIBLE
D YOUNG & CO LLPFeb 28, 2019WITHDRAWN
TIZONA THERAPEUTICSFeb 26, 2019ADMISSIBLE
ABBVIE INC.Feb 15, 2019ADMISSIBLE

The table below shows the patents of Inserm - Institut National De La Santé Et De La Recherche Médicale that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3212200Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative DiseasesJan 20, 20211
EP3256573Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange ChromatographyDec 9, 20201
EP3256574Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification StepNov 25, 20207

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.